Schedule 13D ownership disclosure

AEVI GENOMIC MEDICINE INC

Security class unavailable · CUSIP: 00835P105

Event date: 2019-12-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,946,900
Percent of class
16.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-012387
Form type
SC 13D
Filer
ASTRAZENECA PLC
CIK
CIK 901832
Filed
Feb 07, 2020
Reporting period
Dec 19, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub